Safety of a New Synbiotic Starter Formula.
Study Design
- Loại nghiên cứu
- Observational Study
- Cỡ mẫu
- 280
- Đối tượng nghiên cứu
- Infants fed synbiotic starter formula
- Thời gian
- 12 weeks
- Can thiệp
- Safety of a New Synbiotic Starter Formula. synbiotic infant formula (B. lactis + FOS)
- Đối chứng
- literature benchmarks
- Kết quả chính
- growth and GI symptom incidence
- Xu hướng hiệu quả
- Positive
- Nguy cơ sai lệch
- High
Abstract
PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. RESULTS: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). CONCLUSION: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding.
Tóm lược
The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated, and functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature.
Used In Evidence Reviews
Similar Papers
Alimentary pharmacology & therapeutics · 2009
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.
The American journal of clinical nutrition · 2014
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
World journal of gastroenterology · 2010
Systematic review of randomised controlled trials: probiotics for functional constipation.
Scandinavian journal of gastroenterology · 2011
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.
World journal of gastroenterology · 2008
Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women.
Journal of clinical gastroenterology · 2011